Atezolizumab for Urothelial Cancer, Now Also First-Line Atezolizumab for Urothelial Cancer, Now Also First-Line

Already approved for use in metastatic urothelial carcer, the immunotherapy atezolizumab (Tencentriq, Genentech) can now be used as a first-line treatment.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news